Hormone-mimicking activity
Ethylparaben binds to oestrogen receptors and shows weak oestrogen-like activity in laboratory and animal tests. A 2016 animal study found that oral doses of ethylparaben at 4 mg/kg body weight per day, which approaches the current acceptable daily intake, produced measurable uterotrophic effects in immature female rats, with gene expression changes consistent with oestrogenic action. The estrogenic potency of ethylparaben is considerably lower than endogenous oestrogen, but higher than that of propylparaben or butylparaben in some test systems.
Ethylparaben produced significant uterine weight increases in immature female rats at 4 mg/kg body weight per day, with a no-observed-effect level of 0.8 mg/kg body weight per day, at doses approaching human dietary exposure levels.
2016AnimalSun et al., Scientific Reports
Parabens show weak oestrogen-like activity in laboratory and animal tests and are classified as endocrine-disrupting chemicals, with ethylparaben among those demonstrating receptor-binding activity across more than 25 studies reviewed.
2008Lab + animalDarbre and Harvey, Journal of Applied Toxicology
Anti-androgenic effects and male reproductive system
Parabens, including ethylparaben, can bind to androgen receptors and reduce their activity. An observational study in men found that increasing urinary ethylparaben levels were associated with decreased total sperm motility in some analyses. The longer-chain parabens (propyl, butyl) show stronger anti-androgenic effects than ethyl and methyl parabens, but the class effect applies across the group.
Higher urinary ethylparaben levels were associated with decreased total sperm motility in a case-control study of reproductive-aged men, though statistical significance was limited to unadjusted models in the control group.
2024ObservationalPMC11182354, Association Between Urinary Parabens and Sperm Quality in Nigerian Men
Parabens act as endocrine-disrupting chemicals by exhibiting anti-androgenic activity and perturbing the hypothalamic-pituitary-thyroid axis, with effects observed across the paraben class.
2017Lab + animalRIVM Report 2017-0028, Exposure to and toxicity of methyl-, ethyl- and propylparaben
Prenatal exposure and child behaviour
Several prospective cohort studies have measured paraben levels in pregnant women's urine and followed the children's development. One 2025 study found that gestational exposure to ethylparaben in particular was associated with increased externalising behaviours (such as aggressiveness and hyperactivity) in children assessed at ages 2 to 4. Findings across studies are mixed, and confounding cannot be ruled out in observational research.
Gestational ethylparaben exposure was associated with increased externalising behaviour scores on the Child Behavior Checklist at ages 2, 3 and 4 in a prospective cohort study measuring pooled prenatal urine samples across pregnancy.
2025ObservationalLeader et al., Andrology (Wiley)
Prenatal paraben exposure was associated with altered neurodevelopmental outcomes in some prospective cohort studies, though results across studies are inconsistent and causal inference is limited.
2024ObservationalIdentifying critical windows of prenatal phenol, paraben, and pesticide exposure, PMC10960968
Regulatory ADI and the NOAEL challenge
The EFSA 2004 scientific opinion set a group acceptable daily intake of 0 to 10 mg/kg body weight per day for methyl, ethyl and propyl parabens combined. Subsequent animal studies have challenged the no-observed-adverse-effect level underpinning that figure, reporting effects on puberty timing and uterine weight at doses that fall within or close to the ADI range. EFSA's most recent published assessment for this group dates from 2004, and a formal re-evaluation had not been completed as of 2026.
The EFSA AFC Panel established a group ADI of 0 to 10 mg/kg body weight per day for the paraben food additive group (E214, E215, E218, E219) and noted parabens are not permitted in foods for infants and young children.
2004RegulatoryEFSA AFC Panel Scientific Opinion on para-hydroxybenzoates (E 214-219), EFSA Journal
Some in vivo studies challenge the NOAEL used by EFSA for methyl- and ethylparaben, as it does not account for spermatogenic effects or effects found at lower doses, such as delayed vaginal opening in pre-pubertal rats.
2017Regulatory reviewRIVM Report 2017-0028, Exposure to and toxicity of methyl-, ethyl- and propylparaben